Cited by 662Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

Open access

Adabag, A. Selcuk, Maron, Barry J., Appelbaum, Evan, Harrigan, Caitlin J., Buros, Jacqueline L., Gibson, C. Michael, Lesser, John R., Hanna, Constance A., Udelson, James E., Manning, Warren J., Maron, Martin S.·2008·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2007.11.071

Open this paper in CoChat — free account Open PDF

Abstract

Objectives Our aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in hypertrophic cardiomyopathy (HCM).Background Myocardial fibrosis is identified frequently in HCM; however, the clinical significance of this finding is uncertain.Methods We studied prevalence and frequency of tachyarrhythmias on 24-h ambulatory Holter electrocardiogram (ECG) with regard to delayed enhancement (DE) on contrast-enhanced CMR in 177 HCM patients (age 41 +/- 16 yrs; 95% asymptomatic or mildly symptomatic).Results Premature ventricular contractions (PVCs), couplets, and nonsustained ventricular tachycardia (NSVT) were more common in patients with DE than those without DE (PVCs: 89% vs. 72%; couplets: 40% vs. 17%; NSVT: 28% vs. 4%; p < 0.0001 to 0.007). Patients with DE also had greater numbers of PVCs (202 +/- 655 vs. 116 +/- 435), couplets (1.9 +/- 5 vs. 1.2 +/- 10), and NSVT runs (0.4 +/- 0.8 vs. 0.06 +/- 0.4) than non-DE patients (all p < 0.0001); DE was an independent predictor of NSVT (relative risk 7.3, 95% confidence interval 2.6 to 20.4; p < 0.0001). However, extent (%) of DE was similar in patients with and without PVCs (8.2% vs. 9.1%; p = 0.93), couplets (8.5% vs. 8.4%; p = 0.99), or NSVT (8.3% vs. 8.5%; p = 0.35).Conclusions In this large HCM cohort with no or only mild symptoms, myocardial fibrosis detected by CMR was associated with greater likelihood and increased frequency of ventricular tachyarrhythmias (including NSVT) on ambulatory Holter ECG. Therefore, contrast-enhanced CMR identifies HCM patients with increased susceptibility to ventricular tachyarrhythmias.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2007.11.071

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O. P., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,308
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function
Kim, R. J., Fieno, D. S., Parrish, T. B., Harris, K. R., Chen, E.-L., Simonetti, O. P., Bundy, J. M., Finn, J. P., Klocke, F. J., & Judd, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.19.1992 · Cited by 2,583
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
Self-citation
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Self-citation
Sudden Death in Young Athletes
Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394
Self-citation
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy
Grothues, F., Smith, G. C., Moon, J. C. C., Bellenger, N. G., Collins, P., Klein, H. U., & Pennell, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02381-0 · Cited by 1,267
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J. C., Smith, G., Burman, E., KHAN, M. G., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,163
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
Mahrholdt, H., Wagner, A., Judd, R. M., Sechtem, U. P., & Kim, R. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi258 · Cited by 914
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Self-citation

Show all 43 references

Sorted by citations

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Self-citation
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citation
Hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
Self-citation
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
O’Hanlon, R., Grasso, A. E., Roughton, M., Moon, J., Clark, S., Wage, R., Webb, J., Kulkarni, M., Dawson, D. K., Sulaibeekh, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.010 · Cited by 816
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch‐Herold, M., Kramer, C. M., Manning, W. J., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d44a8f · Cited by 822
Self-citation
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 825
Self-citation
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Ho, C. Y., López, B., Coelho‐Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolı́m, P., Kwong, R. Y. K., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 697
Evaluation of Techniques for the Quantification of Myocardial Scar of Differing Etiology Using Cardiac Magnetic Resonance
Flett, A. S., Hasleton, J. M., Cook, C. P., Hausenloy, D. J., Quarta, G., Ariti, C. A., Muthurangu, V., & Moon, J. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.11.015 · Cited by 691
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells
Lan, F., Lee, A. S., Liang, P., Sanchez-Freire, V., Nguyen, P. K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.010 · Cited by 667
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch‐Herold, M., Kramer, C. M., Manning, W. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.011 · Cited by 591
Self-citation
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
Bruder, O., Wagner, A., Jensen, C. J., Schneider, S., Ong, P., Kispert, E.-M., Naßenstein, K., Schlosser, T. W., Sabin, G. V., Sechtem, U. P., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.007 · Cited by 590
Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy
Maron, M. S., Finley, J., Bos, J. M., Hauser, T. H., Manning, W. J., Haas, T. S., Lesser, J. R., Udelson, J. E., Ackerman, M. J., & Maron, B. J. (2008) · Circulation · doi:10.1161/circulationaha.108.781401 · Cited by 566
Self-citation
MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
Bandettini, W. P., Kellman, P., Mancini, C., Booker, O. J., Vasu, S., Leung, S., Wilson, J. R., Shanbhag, S. M., Chen, M. Y., & Arai, A. E. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-83 · Cited by 517
Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance
Maron, M. S., Maron, B. J., Harrigan, C. J., Buros, J., Gibson, C. M., Olivotto, I., Biller, L. H., Lesser, J. R., Udelson, J. E., Manning, W. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.006 · Cited by 501
Self-citation
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
Karamitsos, T. D., Francis, J. M., Myerson, S. G., Selvanayagam, J. B., & Neubauer, S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.094 · Cited by 466
Human non-contrast T1 values and correlation with histology in diffuse fibrosis
Bull, S., White, S. K., Piechnik, S. K., Flett, A. S., Ferreira, V. M., Loudon, M. A., Francis, J. M., Karamitsos, T. D., Prendergast, B., Robson, M. D., et al. (2013) · Heart · doi:10.1136/heartjnl-2012-303052 · Cited by 462
Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy
Green, J. J., Berger, J. S., Kramer, C. M., & Salerno, M. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.11.021 · Cited by 456
Sudden cardiac death: epidemiology and risk factors
Adabağ, S., Luepker, R. V., Roger, V. L., & Gersh, B. J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.3 · Cited by 430
Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy
Rubinshtein, R., Glockner, J. F., Ommen, S. R., Araoz, P. A., Ackerman, M. J., Sorajja, P., Bos, J. M., Tajik, A. J., Valeti, U. S., Nishimura, R. A., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.854026 · Cited by 418
Noninvasive Detection of Fibrosis Applying Contrast-Enhanced Cardiac Magnetic Resonance in Different Forms of Left Ventricular Hypertrophy
Rudolph, A., Abdel‐Aty, H., Bohl, S., Boyé, P., Zagrosek, A., Dietz, R., & Schulz‐Menger, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.064 · Cited by 384
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
Ho, C. Y., Mealiffe, M. E., Bach, R. G., Bhattacharya, M., Choudhury, L., Edelberg, J. M., Hegde, S. M., Jacoby, D. L., Lakdawala, N. K., Lester, S. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.064 · Cited by 359
American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy
Nagueh, S. F., Bierig, S. M., Budoff, M. J., Desai, M. Y., Dilsizian, V., Eidem, B. W., Goldstein, S. A., Hung, J., Maron, M. S., Ommen, S. R., et al. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.03.006 · Cited by 346
Self-citation
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0212 · Cited by 342
Cardiovascular Magnetic Resonance
Pennell, D. J. (2010) · Circulation · doi:10.1161/circulationaha.108.811547 · Cited by 339
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 326
Self-citation
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
Iles, L., Pflüger, H., Lefkovits, L., Butler, M. J., Kistler, P. M., Kaye, D. M., & Taylor, A. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.062 · Cited by 305
Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
Maron, M. S. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-13 · Cited by 307
Self-citation
The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Maron, B. J., Prasad, S. K., Cecchi, F., Udelson, J. E., & Camici, P. G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.072 · Cited by 306
Self-citation
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J. (2010) · Circulation · doi:10.1161/circulationaha.109.878579 · Cited by 298
Self-citation
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
Girolami, F., Ho, C. Y., Semsarian, C., Baldi, M., Will, M. L., Baldini, K., Torricelli, F., Yeates, L., Cecchi, F., Ackerman, M. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.062 · Cited by 295
Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association
Cardim, N. M., Galderisi, M., Edvardsen, T., Plein, S., Popescu, B. A., D’Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu291 · Cited by 283
Hypertrophic obstructive cardiomyopathy
Veselka, J., Anavekar, N. S., & Charron, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31321-6 · Cited by 257
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.825 · Cited by 279
Self-citation
T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy
Ho, C. Y., Abbasi, S. A., Neilan, T. G., Shah, R. V., Chen, Y., Heydari, B., Cirino, A. L., Lakdawala, N. K., Orav, E. J., González, A., et al. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.000333 · Cited by 259
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B. R., Lamm, D. L., O’Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 255
Cardiac Magnetic Resonance Detection of Myocardial Scarring in Hypertrophic Cardiomyopathy
Kwon, D. H., Smedira, N. G., Rodríguez, E. R., Tan, C. D., Setser, R. M., Thamilarasan, M., Lytle, B. W., Lever, H. M., & Desai, M. Y. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.026 · Cited by 248
Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function
Mentias, A. G., Raeisi‐Giglou, P., Smedira, N. G., Feng, K., Sato, K., Wazni, O. M., Kanj, M., Flamm, S. D., Thamilarasan, M., Popović, Z., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.060 · Cited by 240
Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Moravsky, G., Ofek, E., Rakowski, H., BUTANY, J. W., Williams, L. K., Ralph-Edwards, A. C., Wintersperger, B. J., & Crean, A. M. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.09.018 · Cited by 236
An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease
Linhart, A., Germain, D. P., Olivotto, I., Akhtar, M. M., Anastasakis, A., Hughes, D. A., Namdar, M., Pieroni, M., Hagège, A. A., Cecchi, F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1960 · Cited by 233
Clinical Implications of Midventricular Obstruction in Patients With Hypertrophic Cardiomyopathy
Minami, Y., Kajimoto, K., Terajima, Y., Yashiro, B., Okayama, D., Haruki, S., Nakajima, T., Kawashiro, N., Kawana, M., & Hagiwara, N. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.033 · Cited by 230
Cardiomyopathies: An Overview
Ciarambino, T., Menna, G., Sansone, G., & Giordano, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147722 · Cited by 250
Cardiac MRI: a central prognostic tool in myocardial fibrosis
Ambale‐Venkatesh, B., & Lima, J. A. C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.159 · Cited by 224
Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy
Saito, M., Okayama, H., Yoshii, T., Higashi, H., Morioka, H., Hiasa, G., Sumimoto, T., Inaba, S., Nishimura, K., Inoue, K., et al. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ejechocard/jer318 · Cited by 196
The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
Noureldin, R., Liu, S., Nacif, M. S., Judge, D. P., Halushka, M. K., Abraham, T. P., Ho, C. Y., & Bluemke, D. A. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-17 · Cited by 191
EuroCMR (European Cardiovascular Magnetic Resonance) Registry
Bruder, O., Schneider, S., Nothnagel, D., Dill, T., Hombach, V., Schulz‐Menger, J., Nagel, E. C., Lombardi, M., van Rossum, A. C., Wagner, A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.003 · Cited by 187
Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
Ismail, T. F., Jabbour, A., Gulati, A., Mallorie, A., Raza, S., Cowling, T. E., Das, B., Khwaja, J., Alpendurada, F., Wage, R., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305471 · Cited by 183
Spectrum and Clinical Significance of Systolic Function and Myocardial Fibrosis Assessed by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
Olivotto, I., Maron, B. J., Appelbaum, E. A., Harrigan, C. J., Salton, C. J., Gibson, C. M., Udelson, J. E., O’Donnell, C. J., Lesser, J. R., Manning, W. J., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.020 · Cited by 172
Self-citation
Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
Kuusisto, J., Kärjä, V. J., Sipola, P., Kholová, I., PEUHKURINEN, K. J., Jääskeläinen, P., Naukkarinen, A., Ylä‐Herttuala, S., Punnonen, K. R. A., & Laakso, M. (2012) · Heart · doi:10.1136/heartjnl-2011-300960 · Cited by 168
Hypertrophic Cardiomyopathy: Quantification of Late Gadolinium Enhancement with Contrast-enhanced Cardiovascular MR Imaging
Harrigan, C. J., Peters, D. C., Gibson, C. M., Maron, B. J., Manning, W. J., Maron, M. S., & Appelbaum, E. A. (2010) · Radiology · doi:10.1148/radiol.10090526 · Cited by 166
Self-citation
Histological and Histometric Characterization of Myocardial Fibrosis in End-Stage Hypertrophic Cardiomyopathy
Galati, G., Leone, O., Pasquale, F., Olivotto, I., Biagini, E., Grigioni, F., Pilato, E., Lorenzini, M., Corti, B., Foà, A., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003090 · Cited by 162
Delayed Contrast Enhancement on MR Images of Myocardium: Past, Present, Future
Ordovas, K. G., & Higgins, C. B. (2011) · Radiology · doi:10.1148/radiol.11091882 · Cited by 161
The genetics of dilated cardiomyopathy
Dellefave‐Castillo, L. M., & McNally, E. M. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328337ba52 · Cited by 160
Sudden Cardiac Death
Kuriachan, V. P., Sumner, G., & Mitchell, L. B. (2015) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.01.002 · Cited by 166
Long-Term Outcomes of Combined Epicardial and Endocardial Ablation of Monomorphic Ventricular Tachycardia Related to Hypertrophic Cardiomyopathy
Dukkipati, S. R., d’Ávila, A., Soejima, K., Bala, R., Inada, K., Singh, S. M., Stevenson, W. G., Marchlinski, F. E., & Reddy, V. Y. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.957290 · Cited by 156
Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis
Briasoulis, Α., Mallikethi‐Reddy, S., Palla, M., Alesh, I. G., & Afonso, L. (2015) · Heart · doi:10.1136/heartjnl-2015-307682 · Cited by 150
Progression of Myocardial Fibrosis Assessed With Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
Todiere, G., Aquaro, G. D., Piaggi, P., Formisano, F., Barison, A., Masci, P. G., Strata, E., Bacigalupo, L., Marzilli, M., Pingitore, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.076 · Cited by 149
Relation of Burden of Myocardial Fibrosis to Malignant Ventricular Arrhythmias and Outcomes in Fabry Disease
Krämer, J., Niemann, M., Störk, S., Frantz, S., Beer, M., Ertl, G., Wanner, C., & Weidemann, F. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.06.019 · Cited by 147
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells
Ma, N., Zhang, J. Z., Itzhaki, I., Zhang, S., Chen, H., Haddad, F., Kitani, T., Wilson, K. D., Tian, L., Shrestha, R., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032273 · Cited by 145
Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy
Kubo, T., Kitaoka, H., Yamanaka, S., Hirota, T., Baba, Y., Hayashi, K., Iiyama, T., Kumagai, N., Tanioka, K., Yamasaki, N., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.055 · Cited by 142
Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Vriesendorp, P. A., Schinkel, A. F. L., Liebregts, M., Theuns, D. A. M. J., Cleemput, J. V., ten Cate, F. J., Willems, R., & Michels, M. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002553 · Cited by 141
Etiology of sudden death in the community: Results of anatomical, metabolic, and genetic evaluation
Adabağ, S., Peterson, G. F., Apple, F. S., Titus, J. L., King, R. A., & Luepker, R. V. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.019 · Cited by 143
From Left Ventricular Hypertrophy to Dysfunction and Failure
Lazzeroni, D., Rimoldi, O. E., & Camici, P. G. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0062 · Cited by 137
Hypertrophic cardiomyopathy: genetics and clinical perspectives
Wolf, C. M. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.02.01 · Cited by 139
Assessment of Left Ventricular Hypertrophy in a Trained Athlete: Differential Diagnosis of Physiologic Athlete's Heart From Pathologic Hypertrophy
Pelliccia, A., Maron, M. S., & Maron, B. J. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.01.003 · Cited by 136
Self-citation
Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors
Spirito, P., Autore, C., Formisano, F., Assenza, G. E., Biagini, E., Haas, T. S., Bongioanni, S., Semsarian, C., Devoto, E., Musumeci, B., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.435 · Cited by 131
Self-citation
Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy—Preliminary results
Baeßler, B., Mannil, M., Maintz, D. C., Alkadhi, H., & Manka, R. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.03.013 · Cited by 131
Utility of Cardiovascular Magnetic Resonance in Identifying Substrate for Malignant Ventricular Arrhythmias
White, J. A., Fine, N. M., Gula, L. J., Yee, R. K., Skanes, A. C., Klein, G. J., Leong‐Sit, P., Warren, H., Thompson, T., Drangova, M., et al. (2011) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.966085 · Cited by 128
Nonsustained Ventricular Tachycardia
Katritsis, D. G., Zaręba, W., & Camm, A. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.063 · Cited by 123
Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility
Santangeli, P., Biase, L. D., Lakkireddy, D., Burkhardt, J. D., Pillarisetti, J., Michowitz, Y., Sánchez, J., Horton, R., Mohanty, P. K., Gallinghouse, G. J., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.05.022 · Cited by 121
Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
Doltra, A., Amundsen, B. H., Gebker, R., Fleck, E., & Kelle, S. (2013) · Current Cardiology Reviews · doi:10.2174/1573403x113099990030 · Cited by 121
Assessment of myocardial fibrosis with T1 mapping MRI
Everett, R. J., Stirrat, C., Semple, S. I., Newby, D. E., Dweck, M. R., & Mirsadraee, S. (2016) · Clinical Radiology · doi:10.1016/j.crad.2016.02.013 · Cited by 121
Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis
Satoh, H. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i7.585 · Cited by 121
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 123
Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy
Bos, J. M., Maron, B. J., Ackerman, M. J., Haas, T. S., Sorajja, P., Nishimura, R. A., Gersh, B. J., & Ommen, S. R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.077 · Cited by 102
Self-citation
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 119
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function
Wang, D., Patel, V. V., Ricciotti, E., Zhou, R., Levin, M. D., Gao, E., Zhou, Y., Ferrari, V. A., Lu, M. M., Xu, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805806106 · Cited by 117
Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy
Śpiewak, M., Małek, Ł. A., Miśko, J., Chojnowska, L., Miłosz, B., Kłopotowski, M. M., Petryka, J., Dąbrowski, M., Kępka, C., & Rużyłło, W. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.05.035 · Cited by 116
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy
Lu, D., Pozios, I., Haileselassie, B., Ventoulis, I., Liu, H., Sorensen, L. L., Canepa, M., Phillip, S., Abraham, M. R., & Abraham, T. P. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.006657 · Cited by 111
Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
Lu, F. Y., Ellims, A., Beale, A. L., Taylor, A. J., Murphy, A. J., & Dart, A. M. (2017) · Europe PMC (PubMed Central) · Cited by 109
Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Habib, M., Adler, A., Fardfini, K., Hoss, S., Hanneman, K. A., Rowin, E. J., Maron, M. S., Maron, B. J., Rakowski, H., & Chan, R. H. M. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.09.037 · Cited by 107
Self-citation
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
O’Mahony, C., Elliot, P. M., & McKenna, W. J. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962043 · Cited by 106
Clinical Characteristics and Natural History of Hypertrophic Cardiomyopathy With Midventricular Obstruction
Efthimiadis, G. K., Pagourelias, E. D., Parcharidou, D. G., Gossios, T. D., Kamperidis, V., Theofilogiannakos, E. K., Pappa, Z., Meditskou, S., Hadjimiltiades, S., Pliakos, C. I., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1561 · Cited by 102
Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
Mikami, Y., Kolman, L. R., Joncas, S. X., Stirrat, J., Scholl, D., Rajchl, M., Lydell, C. P., Weeks, S. G., Howarth, A. G., & White, J. A. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-014-0085-x · Cited by 100
Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs
Jiji, R. S., Kramer, C. M., & Salerno, M. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9512-2 · Cited by 98
Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
Almaas, V. M., Haugaa, K. H., Strøm, E. H., Scott, H., Smith, H., Dahl, C. P., Geiran, O. R., Endresen, K., Aakhus, S., Amlie, J., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304923 · Cited by 99
Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy
Fluechter, S., Kuschyk, J., Wolpert, C., Doesch, C., Veltmann, C., Haghi, D., Schoenberg, S. O., Sueselbeck, T., Germans, T., Streitner, F., et al. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-30 · Cited by 96
Predictive Value of Myocardial Delayed Enhancement in Duchenne Muscular Dystrophy
Menon, S. C., Etheridge, S. P., Liesemer, K. N., Williams, R. V., Bardsley, T. R., Heywood, M. C., & Puchalski, M. D. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-0929-z · Cited by 98
Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
To, A. C. Y., Dhillon, A. S., & Desai, M. Y. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.06.022 · Cited by 98
Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively
Schwartz, R. G., Jain, D., & Storozynsky, E. (2013) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9707-1 · Cited by 96
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy
Leonardi, S., Raineri, C., Ferrari, G. M. D., Ghio, S., Scelsi, L., Pasotti, M., Tagliani, M., Valentini, A., Dore, R., Raisaro, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp152 · Cited by 95
Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions
Gerche, A. L., Taylor, A. J., & Prior, D. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.12.011 · Cited by 96
Three-dimensional Deep Convolutional Neural Networks for Automated Myocardial Scar Quantification in Hypertrophic Cardiomyopathy: A Multicenter Multivendor Study
Fahmy, A. S., Neisius, U., Chan, R. H. M., Rowin, E. J., Manning, W. J., Maron, M. S., & Nezafat, R. (2019) · Radiology · doi:10.1148/radiol.2019190737 · Cited by 96
Self-citation
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
Michels, M., Soliman, O. I. I., Phefferkorn, J. E., Hoedemaekers, Y. M., Kofflard, M. J. M., Dooijes, D., Majoor‐Krakauer, D. F., & ten Cate, F. J. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp306 · Cited by 94
Fibroblast-mediated pathways in cardiac hypertrophy
Fujiu, K., & Nagai, R. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.01.013 · Cited by 97
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
Maron, B. J., Rowin, E. J., & Maron, M. S. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.01.019 · Cited by 89
Self-citation
The Many Faces of Hypertrophic Cardiomyopathy: From Developmental Biology to Clinical Practice
Olivotto, I., Girolami, F., Nistri, S., Rossi, A., Rega, L., Garbini, F., Grifoni, C., Cecchi, F., & Yacoub, M. H. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9137-2 · Cited by 88
Prognostic Role of CMR in Patients Presenting With Ventricular Arrhythmias
Dawson, D. K., Hawlisch, K., Prescott, G. J., Roussin, I., Pietro, E. D., Deac, M., Wong, J. L., Frenneaux, M. P., Pennell, D. J., & Prasad, S. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.09.012 · Cited by 87
Narrative Review: Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic Cardiomyopathy
Wang, L., Seidman, J. G., & Seidman, C. E. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-8-201004200-00008 · Cited by 91

Authors: Adabag, A. S., Maron, B. J., Appelbaum, E., Harrigan, C. J., Buros, J. L., Gibson, C. M., Lesser, J. R., Hanna, C. A., Udelson, J. E., Manning, W. J., & Maron, M. S.
Affiliations: Minneapolis Heart Institute Foundation (US)
Beth Israel Deaconess Medical Center (US)
Harvard University (US)
Tufts Medical Center (US)
ORCID: Maron, Barry J.
Buros, Jacqueline L.
Gibson, C. Michael
Lesser, John R.
Udelson, James E.
Manning, Warren J.
Maron, Martin S.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2008-04
Volume: 51
Issue: 14
Pages: 1369-1374
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2007.11.071
OpenAlex: W2076526672
Cited by: 662
References: 43
Citations by year: 2026: 10 · 2025: 12 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 24 · 2020: 24 · 2019: 28 · 2018: 32 · 2017: 29 · 2016: 39 · 2015: 42 · 2014: 64 · 2013: 48 · 2012: 60
FWCI: 50.64
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1932 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Clinical Science Research and Development
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, myocardial fibrosis, late gadolinium enhancement, cardiovascular magnetic resonance, ventricular arrhythmias, non-sustained ventricular tachycardia, premature ventricular contractions, arrhythmogenic substrate, Holter monitoring, asymptomatic patients, arrhythmic risk stratification, contrast-enhanced MRI, cardiac resynchronization therapy, implantable cardioverter-defibrillator
MeSH terms: Adolescent, Adult, Aged, Cardiomyopathy, Hypertrophic, Female, Fibrosis, Health Status Indicators, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Tachycardia, Time Factors, Prevalence, Risk Assessment, Blood Pressure Monitoring, Ambulatory, Ventricular Premature Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks